memoquin

01/01/2013 - "Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease."
12/22/2011 - "Eight monomeric congeners, related to the multitarget lead candidate memoquin, were prepared and evaluated at multiple targets to determine their profile against Alzheimer's disease. "
05/01/2011 - "Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). "
11/23/2007 - "On these premises, memoquin, a multifunctional molecule that was designed to become a drug candidate for the treatment of Alzheimer's disease, was investigated under the reported circular dichroism assay and its anti-amyloidogenic mechanism of action was elucidated."
11/01/2007 - "Memoquin, a recently discovered new drug candidate for the treatment of Alzheimer's disease (AD), is a compound able to interfere with different key targets of AD neurodegeneration. "

01/01/2009 - "The in vitro and in vivo biological profile of memoquin demonstrates the suitability of the new strategy for obtaining innovative drug candidates for the treatment of neurodegenerative diseases."

09/08/2009 - "The photostability properties of memoquin, a multifunctional compound in preclinical development for the treatment of Alzheimer's disease (AD) were investigated in solutions exposed to radiations, using a xenon arc lamp to simulate the natural sunlight. "